Michelle Lock
Chief Executive Officer at RELIEF THERAPEUTICS HOLDING SA
Net worth: - $ as of 30/04/2024
Michelle Lock active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Director/Board Member | 28/01/2022 | - |
| Chief Executive Officer | 01/11/2023 | - |
Career history of Michelle Lock
Former positions of Michelle Lock
| Companies | Position | Start | End |
|---|---|---|---|
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Chief Operating Officer | 07/02/2022 | - |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - | - |
Statistics
International
| Switzerland | 2 |
| United States | 2 |
| Netherlands | 2 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Private companies | 2 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Covis Pharma Holdings BV
Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Michelle Lock
- Experience
